<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="font-style : italic;} Am J Med SciAm. J. Med. SciThe" exact="American" post="Journal of the Medical Sciences0002-96291538-2990Southern Society for Clinical Investigation."/>
 <result pre="for Correspondence: Dr. Mohamed Rafiullah, Assistant Professor, Strategic Center for" exact="Diabetes" post="Research, College of Medicine, King Saud University, PO Box."/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="as the COVID-19 resource centre remains active. Graphical Abstract Abstract" exact="Severe" post="Acute Respiratory Distress Syndrome caused by a novel human"/>
 <result pre="the COVID-19 resource centre remains active. Graphical Abstract Abstract Severe" exact="Acute" post="Respiratory Distress Syndrome caused by a novel human coronavirus"/>
 <result pre="COVID-19 resource centre remains active. Graphical Abstract Abstract Severe Acute" exact="Respiratory" post="Distress Syndrome caused by a novel human coronavirus SARS-CoV-2"/>
 <result pre="centre remains active. Graphical Abstract Abstract Severe Acute Respiratory Distress" exact="Syndrome" post="caused by a novel human coronavirus SARS-CoV-2 named COVID-19"/>
 <result pre="a pandemic. This paper reviews the possibility of repurposing angiotensin" exact="type 1" post="receptor (AT1R) antagonists and vitamin D to treat COVID-19."/>
 <result pre="the target of SARS-CoV-2 for entering into the host cells." exact="Viral" post="spike protein-binding with ACE2 down-regulates it. As ACE2 is"/>
 <result pre="is known to protect the lung from injuries, SARS-CoV-2-induced ACE2" exact="deficiency" post="may expose patients to lung damage. AT1R antagonists and"/>
 <result pre="COVID-19 SARS Introduction A novel human coronavirus named SARS-CoV-2 (severe" exact="acute" post="respiratory syndrome coronavirus 2) emerged from Wuhan, China, since"/>
 <result pre="SARS Introduction A novel human coronavirus named SARS-CoV-2 (severe acute" exact="respiratory" post="syndrome coronavirus 2) emerged from Wuhan, China, since Dec"/>
 <result pre="Introduction A novel human coronavirus named SARS-CoV-2 (severe acute respiratory" exact="syndrome" post="coronavirus 2) emerged from Wuhan, China, since Dec 2019.1"/>
 <result pre="2) emerged from Wuhan, China, since Dec 2019.1 It causes" exact="Acute" post="Respiratory Distress Syndrome (ARDS) in susceptible patients. SARS-CoV-2 binds"/>
 <result pre="emerged from Wuhan, China, since Dec 2019.1 It causes Acute" exact="Respiratory" post="Distress Syndrome (ARDS) in susceptible patients. SARS-CoV-2 binds with"/>
 <result pre="Wuhan, China, since Dec 2019.1 It causes Acute Respiratory Distress" exact="Syndrome" post="(ARDS) in susceptible patients. SARS-CoV-2 binds with angiotensin-converting enzyme"/>
 <result pre="molecule for entry into the human cells.2 The previous SARS-CoV" exact="infections" post="were found to down-regulate the expression of ACE2 molecule.3"/>
 <result pre="Low ACE2 is also reported among aged men5 and in" exact="chronic" post="disease conditions.4 The mortality rate of COVID-19 has been"/>
 <result pre="ACE2 is also reported among aged men5 and in chronic" exact="disease" post="conditions.4 The mortality rate of COVID-19 has been high"/>
 <result pre="among older people and those with pre-existing comorbidities such as" exact="diabetes" post="and hypertension. Decreased levels of ACE2 in SARS-CoV-2 infections"/>
 <result pre="as diabetes and hypertension. Decreased levels of ACE2 in SARS-CoV-2" exact="infections" post="could predispose people to severe COVID-19 complications. Elevating the"/>
 <result pre="them from the lung complications of COVID-19. Treatment with angiotensin" exact="type 1" post="receptor (AT1R) antagonists and vitamin D supplementation may present"/>
 <result pre="entry mechanism of SARS-CoV-2 is similar to that of SARS-CoV." exact="Viral" post="spike S glycoprotein has to be primed by the"/>
 <result pre="the receptors. The SARS-CoV-2 uses ACE2 as the entry receptor.6" exact="Viral" post="entry is dependent on the S protein priming by"/>
 <result pre="10-20 folds higher than that of SARS-CoV. The lung alveolar" exact="epithelial" post="cells, heart, kidney, and enterocytes of the small intestine"/>
 <result pre="to active angiotensin II which in turn binds with angiotensin" exact="type 1" post="receptor (AT1R) to induce vasoconstriction. ACE2 is a counter-regulatory"/>
 <result pre="SARS-CoV spike protein to ACE2 in cell lines and SARS-CoV" exact="infections" post="in animals reduced the expression of ACE2 protein. The"/>
 <result pre="infections in animals reduced the expression of ACE2 protein. The" exact="acute" post="lung injury (ALI) resulting from the SARS-CoV infection was"/>
 <result pre="protein. The acute lung injury (ALI) resulting from the SARS-CoV" exact="infection" post="was shown to be mediated through the down-regulation of"/>
 <result pre="properties. Infusion of angiotensin 1-7 resulted in the attenuation of" exact="vascular" post="dysfunction and atherosclerosis in mice through the activation of"/>
 <result pre="angiotensin 1-7 resulted in the attenuation of vascular dysfunction and" exact="atherosclerosis" post="in mice through the activation of Mas and angiotensin"/>
 <result pre="atherosclerosis in mice through the activation of Mas and angiotensin" exact="type 2" post="(AT2) receptors. The imbalance between angiotensin II and angiotensin"/>
 <result pre="angiotensin 1-7 plays a crucial role in the pathophysiology of" exact="vascular" post="diseases. Lower levels of ACE2 are implicated in several"/>
 <result pre="ACE2 are implicated in several conditions such as hypertension, atherosclerosis," exact="heart" post="failure, diabetic nephropathy, and lung injury.4,10 Expectedly hypertension and"/>
 <result pre="implicated in several conditions such as hypertension, atherosclerosis, heart failure," exact="diabetic nephropathy," post="and lung injury.4,10 Expectedly hypertension and diabetes have been"/>
 <result pre="hypertension, atherosclerosis, heart failure, diabetic nephropathy, and lung injury.4,10 Expectedly" exact="hypertension" post="and diabetes have been the most common comorbidities associated"/>
 <result pre="heart failure, diabetic nephropathy, and lung injury.4,10 Expectedly hypertension and" exact="diabetes" post="have been the most common comorbidities associated with severe"/>
 <result pre="injury.14 In ACE2 deficient conditions, excessive angiotensin II causes increased" exact="vascular" post="permeability, vasoconstriction, and inflammation in the lungs leading to"/>
 <result pre="in the lungs leading to ALI. ACE2 down-regulation by SARS-CoV" exact="infection" post="was found in severe lung failure and was associated"/>
 <result pre="mortality in SARS infection.9 Similarly, in SARS-CoV-2 infection, the ACE2" exact="deficiency" post="after the viral spike binding and the subsequent imbalance"/>
 <result pre="infection.9 Similarly, in SARS-CoV-2 infection, the ACE2 deficiency after the" exact="viral" post="spike binding and the subsequent imbalance in the RAS"/>
 <result pre="higher than healthy individuals and were linearly associated with the" exact="viral" post="load and lung injury.15. Increasing ACE2 levels as a"/>
 <result pre="As ACE2 protein protects the lungs, and COVID-19 patients have" exact="lower" post="levels of ACE2, increasing the ACE2 level is likely"/>
 <result pre="with their use. ACE2 being the target molecule of SARS-CoV-2" exact="viral" post="spike protein, increasing its level may also increase the"/>
 <result pre="viral spike protein, increasing its level may also increase the" exact="viral" post="load. However, the European Society of Cardiology Council on"/>
 <result pre="viral load. However, the European Society of Cardiology Council on" exact="Hypertension" post="stated that there is no evidence supporting any harmful"/>
 <result pre="D has a direct protective effect on the lungs. Its" exact="deficiency" post="appeared to contribute to the ARDS22 and was associated"/>
 <result pre="study on Korean patients with ARDS showed that vitamin D" exact="deficiency" post="was prevalent among them, and the serum levels correlated"/>
 <result pre="receptor to increase ACE2 and angiotensin (1-7). Vitamin D inhibits" exact="pulmonary" post="inflammatory responses and improves the host defense mechanisms against"/>
 <result pre="pulmonary inflammatory responses and improves the host defense mechanisms against" exact="respiratory" post="infections.25 In a meta-analysis of individual patient data from"/>
 <result pre="randomized controlled trials, vitamin D supplementation reduced the risk of" exact="acute" post="respiratory tract infection among participants26 A review showed the"/>
 <result pre="controlled trials, vitamin D supplementation reduced the risk of acute" exact="respiratory" post="tract infection among participants26 A review showed the effect"/>
 <result pre="vitamin D supplementation reduced the risk of acute respiratory tract" exact="infection" post="among participants26 A review showed the effect of vitamin"/>
 <result pre="A review showed the effect of vitamin D in lowering" exact="viral" post="epidemics, respiratory tract infections, and the reduction of inflammatory"/>
 <result pre="showed the effect of vitamin D in lowering viral epidemics," exact="respiratory" post="tract infections, and the reduction of inflammatory responses in"/>
 <result pre="and vitamin D to prevent or lessen the severity of" exact="acute" post="lung complications of COVID-19 needs investigation. These widely available,"/>
 <result pre="with vitamin D. References References 1World Health Organization.Naming the coronavirus" exact="disease" post="(COVID-19) and the virus that causes it. Country &amp;amp;"/>
 <result pre="virus that causes it. Country &amp;amp; Technical Guidance - Coronavirus" exact="disease" post="(COVID-19). Available at:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Published 2020. Accessed March 18, 2020."/>
 <result pre="the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long" exact="Structural" post="Studies of SARS Coronavirus. Gallagher T, edJ Virol94202010.1128/JVI.00127-20e00127-20 3DijkmanRJebbinkMFDeijsMReplication-dependent"/>
 <result pre="a Clinically Proven Protease Inhibitor. Cell. 2020: 1-10. doi:10.1016/j.cell.2020.02.052 7ZhouPYangX-LWangX-GA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="2 (ACE2) in SARS coronavirusâ€&quot;induced lung injuryNat Med11200587587910.1038/nm126716007097 10ChristosTI.JCM.FJCharacterization of" exact="Renal" post="Angiotensin-Converting Enzyme 2 in Diabetic NephropathyHypertension41200339239710.1161/01.HYP.0000060689.38912.CB12623933 11GuanW-JNiZ-YHuYChina Medical Treatment"/>
 <result pre="Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus" exact="Disease" post="2019 in ChinaN Engl J Med202011310.1056/NEJMoa2002032 12WangDHuBHuCClinical Characteristics of"/>
 <result pre="12WangDHuBHuCClinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected" exact="Pneumonia" post="in Wuhan, ChinaJAMA - J Am Med Assoc20201910.1001/jama.2020.1585 13ZhangJ"/>
 <result pre="J Allergy Clin Immunol00202011210.1111/all.14238 14ImaiYKubaKRaoSAngiotensin-converting enzyme 2 protects from severe" exact="acute" post="lung failureNature436200511211610.1038/nature0371216001071 15LiuYYangYZhangCClinical and biochemical indexes from 2019-nCoV infected"/>
 <result pre="15LiuYYangYZhangCClinical and biochemical indexes from 2019-nCoV infected patients linked to" exact="viral" post="loads and lung injurySci China Life Sci63202036437410.1007/s11427-020-1643-832048163 16Simone G"/>
 <result pre="Sci63202036437410.1007/s11427-020-1643-832048163 16Simone G de.Position Statement of the ESC Council on" exact="Hypertension" post="on ACE-Inhibitors and Angiotensin Receptor Blockers. Position Statement.https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang. Published"/>
 <result pre="novel coronavirus outbreakBMJ3682020m40610.1136/bmj.m40632005675 20LiYCMolecular mechanism of vitamin D in the" exact="cardiovascular" post="systemJ Investig Med59201186887110.2310/JIM.0b013e31820ee448 21XuJYangJChenJVitamin D alleviates lipopolysaccharide-induced acute lung"/>
 <result pre="in the cardiovascular systemJ Investig Med59201186887110.2310/JIM.0b013e31820ee448 21XuJYangJChenJVitamin D alleviates lipopolysaccharide-induced" exact="acute" post="lung injury via regulation of the renin-angiotensin systemMol Med"/>
 <result pre="via regulation of the renin-angiotensin systemMol Med Rep1620177432743810.3892/mmr.2017.754628944831 22DancerRCAParekhDLaxSVitamin D" exact="deficiency" post="contributes directly to the acute respiratory distress syndrome (ARDS)Thorax70201561762410.1136/thoraxjnl-2014-20668025903964"/>
 <result pre="systemMol Med Rep1620177432743810.3892/mmr.2017.754628944831 22DancerRCAParekhDLaxSVitamin D deficiency contributes directly to the" exact="acute" post="respiratory distress syndrome (ARDS)Thorax70201561762410.1136/thoraxjnl-2014-20668025903964 23RemmeltsHHFvan de GardeEMWMeijvisSCAAddition of Vitamin"/>
 <result pre="Med Rep1620177432743810.3892/mmr.2017.754628944831 22DancerRCAParekhDLaxSVitamin D deficiency contributes directly to the acute" exact="respiratory" post="distress syndrome (ARDS)Thorax70201561762410.1136/thoraxjnl-2014-20668025903964 23RemmeltsHHFvan de GardeEMWMeijvisSCAAddition of Vitamin D"/>
 <result pre="22DancerRCAParekhDLaxSVitamin D deficiency contributes directly to the acute respiratory distress" exact="syndrome" post="(ARDS)Thorax70201561762410.1136/thoraxjnl-2014-20668025903964 23RemmeltsHHFvan de GardeEMWMeijvisSCAAddition of Vitamin D Status to"/>
 <result pre="Outcome in Community-Acquired PneumoniaClin Infect Dis5520121488149410.1093/cid/cis75122942205 24ParkSLeeMGHongSBEffect of vitamin D" exact="deficiency" post="in korean patients with acute respiratory distress syndromeKorean J"/>
 <result pre="Dis5520121488149410.1093/cid/cis75122942205 24ParkSLeeMGHongSBEffect of vitamin D deficiency in korean patients with" exact="acute" post="respiratory distress syndromeKorean J Intern Med3320181129113610.3904/kjim.2017.38029914229 25HughesDANortonRVitamin D and"/>
 <result pre="24ParkSLeeMGHongSBEffect of vitamin D deficiency in korean patients with acute" exact="respiratory" post="distress syndromeKorean J Intern Med3320181129113610.3904/kjim.2017.38029914229 25HughesDANortonRVitamin D and respiratory"/>
 <result pre="acute respiratory distress syndromeKorean J Intern Med3320181129113610.3904/kjim.2017.38029914229 25HughesDANortonRVitamin D and" exact="respiratory" post="healthClin Exp Immunol1582009202510.1111/j.1365-2249.2009.04001.x19737226 26MartineauARJolliffeDAHooperRLVitamin D supplementation to prevent acute"/>
 <result pre="and respiratory healthClin Exp Immunol1582009202510.1111/j.1365-2249.2009.04001.x19737226 26MartineauARJolliffeDAHooperRLVitamin D supplementation to prevent" exact="acute" post="respiratory tract infections: systematic review and meta-analysis of individual"/>
 <result pre="respiratory healthClin Exp Immunol1582009202510.1111/j.1365-2249.2009.04001.x19737226 26MartineauARJolliffeDAHooperRLVitamin D supplementation to prevent acute" exact="respiratory" post="tract infections: systematic review and meta-analysis of individual participant"/>
 <result pre="27GrantWBLahoreHMcDonnellSLVitamin D Supplementation Could Prevent and Treat Influenza, Coronavirus, and" exact="Pneumonia" post="InfectionsNutrients12202098810.20944/PREPRINTS202003.0235.V1 28GaramiARRapid Response: Re: Preventing a covid-19 pandemic -"/>
 <result pre="Kingdom of Saudi Arabia, grant to the Strategic Center for" exact="Diabetes" post="Research, the College of Medicine, King Saud University. Conflicts"/>
</results>
